Politics & Law
Prescriptions and Power: Why Eli Lilly Is Suing Compounding Pharmacies Over Weight Loss Drugs
In the escalating battle over obesity treatment in the United States, the pharmaceutical industry has found an unexpected foe: local...
Read more
Science vs. Slogan: The Growing Rift Between RFK Jr. and the Public Health Establishment
On April 15, a coalition of 17 national public health organizations, spearheaded by the American Public Health Advocacy Network (APHAN),...
Read more
The Silence Clause: NIH Halts Grants to Top Universities Amid Veiled Directives
On a quiet Tuesday afternoon in March, a cryptic internal email circulated through the National Institutes of Health (NIH), addressed...
Read more
Medical Journals Under Scrutiny: DOJ’s Quiet Inquiry Into Scientific Dissent
In the wake of COVID-19 and the increasing politicization of public health, the U.S. Department of Justice has taken an...
Read more
The Physician on Trial: A Broken System, A Profession Reborn
Bad news travels fast. But good news? That takes time. And when it comes to the federal prosecution of physicians,...
Read more
What Happens When the Match Ends? States Brace for Impact as CMS Shifts Medicaid Funding Rules
When a federal agency changes the way money flows, the effects aren’t always immediate — but they’re often profound. In...
Read more
Where Medicine Meets Morality: How Specialty Societies Responded to the Gaza-Israel Conflict
In the early days of the Gaza-Israel conflict, images of devastation filled screens and newspapers around the world. Hospitals overwhelmed,...
Read more
The Data Dilemma: What 23andMe’s Bankruptcy Means for the Future of Medical Data Ownership
The news of 23andMe’s financial instability and potential bankruptcy isn’t just another tech-company flameout. It’s a watershed moment for the...
Read more
From Academia to Algorithms: Vinay Prasad and the Rise of Populist Medicine Online
Healthcare has always existed at the intersection of science, politics, and public trust. But in today’s digital era, the loudest...
Read more
Robert F. Kennedy Jr. : A Healthcare Disruptor with a Vision for Reform
Introduction: The Healthcare Disruptor We Need? Robert F. Kennedy Jr. has made waves as a political figure, environmental lawyer, and...
Read more
Telehealth in Turmoil
The COVID-19 pandemic served as a catalyst for the rapid adoption of telehealth services across the United States. As in-person...
Read more
From Statutes to Case Law: Why Physicians Must Step Into the Legal Arena
For most physicians, the difference between statutory law and case law might seem as irrelevant as the difference between Shakespearean...
Read more
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more